Medical, Healthcare and Life Sciences Company Incubation
Cardiff Medicentre has previously incubated a number of highly successful early-stage companies operating in the medical, healthcare and life sciences sectors.
Following their graduation from this facility, these companies have gone on to occupy their own bespoke facilities, raise substantial amounts of venture capital or be acquired by larger companies.
Recent examples of successful Cardiff Medicentre graduates are:
Biodynamics Research Ltd was acquired by Quotient BioResearch Ltd in February 2008. BioDynamics was a leading, specialist provider of metabolism, bioanalytical and radiochemistry services to the world-wide pharmaceutical and biotechnology industries.
To read the Quotient Research press release, please click here.
In November 2010, Cardiff Bioanalytical Services Ltd was acquired by LGC Ltd. Cardiff Bioanalytical Services was a leading provider of External Quality Assessment schemes for clinical and forensic toxicology and therapeutic drug monitoring.
To read the LGC press release, please click here.
In July 2006, Inflexion Private Equity led the acquisition of Cardiff Research Consortium on behalf of its portfolio company Healthcare Knowledge International, which consisted of CHKS, its UK division, and Iasist in Spain.
To read the Inflexion Private Equity press release, please click here.
Outsourcing giant Capita Group plc then purchased Cardiff Research Consortium in February 2009 as part of its £11.6m acquisition of CHKS.
To read the Capita Group press release, please click here.
onExamination was acquired by BMJ Group in December 2007. onExamination was formed by two doctors from Cardiff University who saw the potential of the internet to help doctors prepare for examinations.
To read the BMJ Group press release, please click here.
Q Chip completed a $6 million funding round in May 2011. Q Chip Ltd is a biopharmaceutical company developing sustained release injectable depot formulations.
To read the Q Chip press release, please click here.
Tricho-Tech was acquired by Concateno plc for £11.25 million in January 2007. Tricho-Tech focused on detecting drugs of abuse, principally through testing hair samples.
To read the Concateno press release, please click here.